Gyre Therapeutics Inc.
(GYRE)
undefined
undefined%
At close: undefined
10.30
6.19%
After-hours Dec 13, 2024, 05:53 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 |
Revenue | 113.45M | 794.00K | 7.34M | 20.95M | - | 6.00K | 1.02M | 399.00K | 1.75M | 275.00K | 3.63M | 57.86M | 97.64M | 85.71M | 25.06M | 20.09M | 11.58M | 27.54M | 1.18M | 3.74M | 2.46M | 2.29M | 1.70M |
Cost of Revenue | 4.64M | 798.00K | 7.38M | 9.16M | 43.86M | 21.47M | 12.85M | 10.55M | 5.96M | 5.27M | 6.56M | - | - | - | 691.00K | 749.00K | 715.42K | 457.25K | 480.93K | 198.45K | 743.00K | 244.00K | - |
Gross Profit | 108.81M | -4.00K | -42.00K | 11.79M | -43.86M | -21.47M | -11.83M | -10.16M | -4.21M | -4.99M | -2.93M | 57.86M | 97.64M | 85.71M | 24.37M | 19.34M | 10.86M | 27.08M | 698.98K | 3.54M | 1.72M | 2.04M | 1.70M |
Operating Income | -67.23M | -8.61M | -87.89M | -57.37M | -57.28M | -33.82M | -21.82M | -20.42M | -13.80M | -29.71M | -47.22M | -8.14M | -9.74M | 13.12M | -40.33M | -28.14M | -31.77M | -403.69K | -29.94M | -24.39M | -20.06M | -21.00M | -8.75M |
Interest Income | - | 537.00K | 39.00K | 1.13M | 2.10M | 3.77M | 261.00K | 3.47M | 518.00K | 585.00K | 784.00K | 1.07M | 1.22M | 1.46M | 1.05M | 2.73M | - | - | - | - | - | - | - |
Pretax Income | -76.97M | -7.89M | -87.93M | -56.24M | -55.18M | -30.05M | -21.56M | -16.95M | -14.76M | -29.14M | -46.70M | -7.10M | -8.53M | 14.43M | -39.49M | -25.66M | -28.07B | -1.24B | - | -24.40M | - | - | - |
Net Income | -92.93M | 2.30M | -87.93M | -55.54M | -52.89M | -30.05M | -21.56M | -16.95M | -14.76M | -32.62M | -46.70M | -7.00M | -8.53M | 10.90M | -39.40M | -25.66M | -28.07M | 2.10M | -28.99M | -24.03M | -19.39M | -21.07M | -7.30M |
Selling & General & Admin | 75.82M | 17.37M | 18.96M | 16.18M | 13.42M | 12.35M | 9.99M | 9.26M | 9.59M | 10.17M | 12.01M | 13.19M | 12.17M | 8.05M | 8.17M | 6.50M | 8.01M | 5.70M | 6.39M | 5.16M | 3.60M | 4.13M | 2.30M |
Research & Development | 13.78M | 13.04M | 68.89M | 52.98M | 43.86M | 21.47M | 12.85M | 11.55M | 5.96M | 19.50M | 38.84M | 49.09M | 95.22M | 64.55M | 40.18M | 40.98M | 34.62M | 21.79M | 24.25M | 22.77M | 18.18M | 16.24M | 8.15M |
Other Expenses | 86.44M | -517.00K | -78.00K | 568.00K | -46.00K | 1.65M | 261.00K | 86.00K | - | 318.00K | 518.00K | 1.04M | - | - | 51.28M | 32.01M | 27.33B | 16.77B | - | - | - | - | - |
Operating Expenses | 176.04M | 30.40M | 87.85M | 69.16M | 57.28M | 33.83M | 22.84M | 20.82M | 15.55M | 29.67M | 50.84M | 62.28M | 107.38M | 72.60M | 64.70M | 47.48M | 42.63M | 27.48M | 30.64M | 27.93M | 21.78M | 23.05M | 10.45M |
Interest Expense | - | 717.00K | - | - | - | - | - | - | 1.48M | 23.00K | 53.00K | 86.00K | 132.00K | 153.00K | 217.00K | 251.00K | - | - | - | - | - | - | - |
Selling & Marketing Expenses | 61.16M | 54.24M | 44.65M | - | - | - | - | - | - | - | - | - | - | - | - | - | -8.00B | -5.69B | - | - | - | - | - |
Cost & Expenses | 180.68M | 31.20M | 95.23M | 78.32M | 57.28M | 33.83M | 22.84M | 20.82M | 15.55M | 29.67M | 50.84M | 62.28M | 107.38M | 72.60M | 65.39M | 48.23M | 43.35M | 27.94M | 31.12M | 28.13M | 22.52M | 23.29M | 10.45M |
Income Tax | 8.52M | 348.00K | -39.00K | -699.00K | -2.29M | 3.77M | -173.00K | 3.08M | 518.00K | 3.48M | 7.00K | -101.00K | -2.48M | 3.53M | -88.00K | -4.28M | -3.70M | -2.50M | -949.39K | -368.04K | 19.39M | 21.07M | 7.30M |
Shares Outstanding (Basic) | 65.83M | 76.74M | 30.64M | 19.18M | 12.00M | 11.21M | 3.42M | 778.78K | 295.27K | 321.72K | 320.38K | 318.82K | 301.31K | 271.84K | 244.16K | 234.90K | 187.82K | 129.48K | 2.50K | 2.09K | 1.04K | 2.60K | 2.60K |
Shares Outstanding (Diluted) | 65.83M | 75.69M | 30.64M | 19.18M | 12.00M | 11.21M | 3.42M | 778.78K | 295.27K | 321.72K | 320.38K | 318.82K | 301.31K | 287.15K | 244.16K | 234.90K | 187.82K | 129.48K | 2.50K | 2.09K | 1.04K | 2.60K | 2.60K |
EPS (Basic) | -1.41 | 0.04 | -2.87 | -2.9 | -4.41 | -2.68 | -6.3 | -21.76 | -49.99 | -101.4 | -145.78 | -21.95 | -28.31 | 39.90 | -161.39 | -109.24 | -149.47 | -9.45 | -11.62K | -11.51K | -18.68K | -8.10K | -2.81K |
EPS (Diluted) | -1.41 | 0.03 | -2.87 | -2.9 | -4.41 | -2.68 | -6.3 | -21.76 | -49.99 | -101.4 | -145.78 | -21.95 | -28.31 | 37.80 | -161.39 | -109.24 | -149.47 | -9.45 | -11.62K | -11.51K | -18.68K | -8.10K | -2.81K |
EBITDA | 20.33M | 10.33M | -87.60M | -57.37M | -57.28M | -33.82M | -21.82M | -16.95M | -12.81M | -29.71M | -47.22M | -8.14M | -9.74M | 13.12M | -40.33M | -28.14M | -30.86M | 417.23K | -29.14M | -23.13M | -20.06M | -21.00M | -8.75M |
Depreciation & Amortization | 1.11M | 1.13M | 290.00K | 138.00K | 146.00K | 149.00K | 173.00K | 389.00K | 470.00K | 351.00K | 547.00K | 2.21M | 2.48M | 2.00M | 1.83M | 1.80M | 907.16K | 820.92K | 803.18K | 766.34K | - | - | - |